Science Explorer Back to mapMap
Discussion
Company · Palo Alto · United States

Jazz Pharmaceuticals (United States)

In research, Jazz Pharmaceuticals (United States) stands highest in Health Sciences (#11,102 of 16,688 worldwide) and Medicine (#10,120 of 14,558 worldwide), over all time. Relative to its size it is most specialised in Cognitive Neuroscience and Neuroscience (Cognitive Neuroscience is 28.4× its share of world research).

jazzpharma.comROR OpenAlex
World rank, 2022-now
#21,548
of 22,385 · #28,965 all time
Rank in United States
#3,191
of 3,332
Research works
276
▲ 38% vs 2018-21
Citations
4.3k
15.5 per fractional work
Top-10% rate
7.6%
all institutions 10.0%
vs its own fields
0.89×
1.00× is exactly expected
Open access
47%
world 40%
International
31%
world 18%
Jazz Pharmaceuticals (United States)

What is Jazz Pharmaceuticals (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #11,102 of 16,688 12.2%138
MedicineField #10,120 of 14,558 12.0%132

Each strip is that field's whole ranked pool, with the notch where Jazz Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Jazz Pharmaceuticals (United States) work in?

In 2022-now, 47% of research at Jazz Pharmaceuticals (United States) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (44%), Neuroscience (23%), Psychology (13%). It does 2.2× the world's share of Life Sciences.

Health Sciences: 56 fractional works · 47.2% of its workMedicine: 53 fractional works · 44.1% of its workOncology: 10 fractional works · 8.4% of its workPulmonary and Respiratory Medicine: 6 fractional works · 4.7% of its workPharmacology: 5 fractional works · 4.5% of its workPhysiology: 5 fractional works · 3.8% of its workHematology: 4 fractional works · 3.8% of its workEpidemiology: 3 fractional works · 2.9% of its workPsychiatry and Mental health: 3 fractional works · 2.4% of its workNeurology: 3 fractional works · 2.4% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 2.1% of its workPathology and Forensic Medicine: 2 fractional works · 1.7% of its workSurgery: 2 fractional works · 1.4% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 1.4% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.2% of its workRheumatology: 1 fractional works · 1.1% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 0.8% of its workGenetics: 1 fractional works · 0.8% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNursing: 2 fractional works · 2.0% of its workNutrition and Dietetics: 2 fractional works · 2.0% of its workHealth Professions: 1 fractional works · 0.9% of its workGeneral Health Professions: 1 fractional works · 0.6% of its workSpeech and Hearing: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workLife Sciences: 39 fractional works · 32.3% of its workNeuroscience: 28 fractional works · 23.1% of its workCognitive Neuroscience: 25 fractional works · 20.7% of its workCellular and Molecular Neuroscience: 2 fractional works · 1.5% of its workEndocrine and Autonomic Systems: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 8.0% of its workMolecular Biology: 5 fractional works · 4.6% of its workGenetics: 2 fractional works · 1.9% of its workCancer Research: 1 fractional works · 0.8% of its workCell Biology: 0 fractional works · 0.3% of its workClinical Biochemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.8% of its workToxicology: 1 fractional works · 0.5% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 0.3% of its workImmunology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.0% of its workSocial Sciences: 21 fractional works · 17.3% of its workPsychology: 16 fractional works · 13.2% of its workExperimental and Cognitive Psychology: 15 fractional works · 13.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.1% of its workEconomics and Econometrics: 1 fractional works · 1.1% of its workDecision Sciences: 1 fractional works · 0.9% of its workInformation Systems and Management: 1 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 1 fractional works · 0.8% of its workManagement of Technology and Innovation: 1 fractional works · 0.8% of its workSocial Sciences: 1 fractional works · 0.7% of its workEducation: 0 fractional works · 0.3% of its workHealth: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 1 fractional works · 0.6% of its workArcheology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 4 fractional works · 3.2% of its workChemistry: 1 fractional works · 1.2% of its workAnalytical Chemistry: 1 fractional works · 0.9% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 1 fractional works · 0.5% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.4% of its workComputer Science: 0 fractional works · 0.4% of its workComputational Theory and Mathematics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workCondensed Matter Physics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.2% of its workStatistics and Probability: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 0 fractional works · 0.2% of its workALL ITS WORKJazzPharmaceuticals…120fractional works, 2022-now
Life Sciences32%Physical Sciences3%Health Sciences47%Social Sciences17%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine5344.1%
    2. Nursing22.0%
    3. Health Professions10.9%
    4. Veterinary00.2%
    1. Neuroscience2823.1%
    2. Biochemistry, Genetics and Molecular Biology108.0%
    3. Pharmacology, Toxicology and Pharmaceutics10.8%
    4. Immunology and Microbiology00.3%
    5. Agricultural and Biological Sciences00.0%
    1. Psychology1613.2%
    2. Economics, Econometrics and Finance11.1%
    3. Decision Sciences10.9%
    4. Business, Management and Accounting10.8%
    5. Social Sciences10.7%
    6. Arts and Humanities10.6%
    1. Chemistry11.2%
    2. Engineering10.5%
    3. Materials Science00.4%
    4. Computer Science00.4%
    5. Physics and Astronomy00.4%
    6. Mathematics00.2%
    7. Environmental Science00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Jazz Pharmaceuticals (United States) specialise in?

Where its research is concentrated relative to its size: Cognitive Neuroscience takes 28.4× the share of its output that it takes of world research.

  1. Cognitive NeuroscienceSubfield · 24.8 works28×
  2. NeuroscienceField · 27.6 works14×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.01× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.50× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 0.29× its world share, 0 worksImmunology and Micro…Neuroscience: 14.24× its world share, 28 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.35× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.79× its world share, 2 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEngineering: 0.03× its world share, 1 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.12× its world share, 0 worksMaterials ScienceMathematics: 0.20× its world share, 0 worksMathematicsPhysics and Astronomy: 0.16× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.35× its world share, 1 worksHealth ProfessionsMedicine: 2.29× its world share, 53 worksMedicineNursing: 4.00× its world share, 2 worksNursingVeterinary: 1.56× its world share, 0 worksVeterinaryArts and Humanities: 0.19× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.26× its world share, 1 worksBusiness, Management…Decision Sciences: 0.94× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.53× its world share, 1 worksEconomics, Econometr…Psychology: 4.33× its world share, 16 worksPsychologySocial Sciences: 0.06× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 14.2×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Neuroscience14.24×28 works
  2. Psychology4.33×16 works
  3. Nursing4.00×2 works
  4. Pharmacology, Toxicology and Pharmaceutics2.35×1 works
  5. Medicine2.29×53 works
  6. Veterinary1.56×0 works
  7. Biochemistry, Genetics and Molecular Biology1.50×10 works
  8. Decision Sciences0.94×1 works
  9. Chemistry0.79×2 works
  10. Economics, Econometrics and Finance0.53×1 works
  11. Health Professions0.35×1 works
  12. Immunology and Microbiology0.29×0 works
  13. Business, Management and Accounting0.26×1 works
  14. Mathematics0.20×0 works
  15. Arts and Humanities0.19×1 works
  16. Physics and Astronomy0.16×0 works
  17. Materials Science0.12×0 works
  18. Social Sciences0.06×1 works
  19. Computer Science0.05×0 works
  20. Engineering0.03×1 works
  21. Environmental Science0.03×0 works
  22. Agricultural and Biological Sciences0.01×0 works

Who are the top researchers at Jazz Pharmaceuticals (United States)?

Ranked on the quality score, Geertrui F. Vanhove, Moise A. Khayrallah and Jed E. Black lead among researchers whose main affiliation is Jazz Pharmaceuticals (United States).

  1. 1 Geertrui F. Vanhove United States · #677,365 worldwide 2.7k citations · 74 works
  2. 2 Moise A. Khayrallah United States · #710,712 worldwide 2.8k citations · 18 works
  3. 3 Jed E. Black United States · #843,845 worldwide 7.1k citations · 193 works
  4. 4 Bijan Nejadnik United States · #1,037,881 worldwide 3.2k citations · 52 works
  5. 5 Jessica K. Alexander United States · #1,038,179 worldwide 4.8k citations · 37 works
  6. 6 Guojun Yuan United States · #1,079,272 worldwide 1.8k citations · 36 works
  7. 7 Diane Guinta United States · #1,199,541 worldwide 1.1k citations · 24 works
  8. 8 Maja Miloslavsky United States · #1,206,436 worldwide 3k citations · 19 works
  9. 9 Neil T. Feldman United States · #1,261,378 worldwide 3.5k citations · 57 works
  10. 10 Douglas S. Fuller United States · #1,264,291 worldwide 3.2k citations · 143 works
All ranked researchers at Jazz Pharmaceuticals (United States)

What are the most cited papers from Jazz Pharmaceuticals (United States)?

The most cited paper from Jazz Pharmaceuticals (United States) is "Ghrelin" (Timo D. Müller et al., 2015), with 1,036 citations. Next come "The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway" (729) and "Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist" (489).

Most cited papers
#PaperReleasedCitations
1 Ghrelin Timo D. Müller et al. · Molecular Metabolism Open access 7 Apr 2015 1,036
2 The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway Richard M. Lawn, David P. Wade, Michael R. Garvin et al. · Journal of Clinical Investigation Open access 15 Oct 1999 729
3 Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist Peter Kühnen, Karine Clément, Susanna Wiegand et al. · New England Journal of Medicine 20 Jul 2016 489
4 Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials Karine Clément et al. · The Lancet Diabetes & Endocrinology 30 Oct 2020 481
5 Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model Masashi Kitazawa, David Cheng, Michelle R. Tsukamoto et al. · The Journal of Immunology Open access 17 Nov 2011 472
All 61 most cited papers, with filters and sorting

Which keywords describe research at Jazz Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Circadian Rhythms, Memory, Sleep, Epidemiology, Meta-Analysis, Insomnia, Sleep Duration and Neurological Disorders.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Circadian Rhythms35▲ 270×2 topics
  2. Memory22▲ 76×1 topic
  3. Sleep22▲ 460×1 topic
  4. Epidemiology20▲ 4.3×14 topics
  5. Meta-Analysis13▲ 19×3 topics
  6. Insomnia13▲ 146×1 topic
  7. Sleep Duration13▲ 157×1 topic
  8. Neurological Disorders10▲ 15×13 topics
  9. Prognostic Factors10▲ 19×8 topics
  10. Chemotherapy9▲ 10×11 topics
  11. Clinical Trials8▲ 9.4×9 topics
  12. Targeted Therapy6▲ 23×4 topics
  13. Inflammation6▲ 2.3×19 topics
  14. Cardiovascular Disease6▲ 4.2×10 topics
  15. Epilepsy5▲ 41×4 topics
  16. Immunotherapy5▲ 6.3×8 topics
  17. Hypertension5▲ 15×4 topics
  18. Diagnostic Criteria4▲ 16×5 topics
  19. Metabolic Disorders4▲ 32×3 topics
  20. Quality of Life4▲ 2.6×9 topics
  21. Neuroprotection4▲ 11×2 topics
  22. Biomarkers4▲ 5.2×5 topics
  23. Metastasis4▲ 11×2 topics
  24. Cannabinoid Receptors4▲ 106×1 topic
  25. Endocannabinoid System4▲ 106×1 topic
  26. Genomic Profiles4▲ 79×1 topic
  27. Hematopoietic Stem Cells4▲ 39×3 topics
  28. Metabolic Syndrome4▲ 4.2×10 topics
  29. Small-Cell Lung Cancer4▲ 79×1 topic
  30. Cancer Therapy4▲ 5.1×9 topics
  31. Genetic Mutations3▲ 6.5×10 topics
  32. Insulin Resistance3▲ 6.4×5 topics
  33. Metabolism3▲ 5.1×8 topics
  34. Antiepileptic Drugs3▲ 30×2 topics
  35. Obstructive Sleep Apnea3▲ 50×1 topic
  36. Sleep-Disordered Breathing3▲ 50×1 topic
  37. Breast Cancer3▲ 8.7×6 topics
  38. Fatigue3▲ 19×2 topics
  39. Neurobiology3▲ 8.4×4 topics
  40. Shift Work2▲ 65×1 topic

Which research topics does Jazz Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Sleep and Wakefulness Research, Sleep and related disorders, Cannabis and Cannabinoid Research and Lung Cancer Research Studies.

Sleep and Wakefulness Re…22Sleep and Wakefulness Research: 22 fractional worksSleep and related disord…13Sleep and related disorders: 13 fractional worksCannabis and Cannabinoid Research: 4 fractional worksLung Cancer Research Studies: 4 fractional worksObstructive Sleep Apnea Research: 3 fractional worksSleep and Work-Related Fatigue: 2 fractional worksEpilepsy research and treatment: 2 fractional worksRestless Legs Syndrome Research: 2 fractional worksAcute Myeloid Leukemia Research: 2 fractional worksAcute Lymphoblastic Leukemia research: 2 fractional works
Cognitive NeuroscienceExperimental and Cognitive PsychologyPharmacologyOncology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Sleep and Wakefulness Research Cognitive Neuroscience 22 works
  2. 2 Sleep and related disorders Experimental and Cognitive Psychology 13 works
  3. 3 Cannabis and Cannabinoid Research Pharmacology 4 works
  4. 4 Lung Cancer Research Studies Oncology 4 works
  5. 5 Obstructive Sleep Apnea Research Physiology 3 works
  6. 6 Sleep and Work-Related Fatigue Experimental and Cognitive Psychology 2 works
  7. 7 Epilepsy research and treatment Psychiatry and Mental health 2 works
  8. 8 Restless Legs Syndrome Research Epidemiology 2 works
  9. 9 Acute Myeloid Leukemia Research Hematology 2 works
  10. 10 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.7%not open53.3%

World: 40% of research is openly available.

with international co-authors31.0%domestic only69.0%

World: 18% is written across borders.

How has Jazz Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 38% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Jazz Pharmaceuticals (United States) as a percentage of every work published that year, 0.00049% in 2024.

still counting0.00025%0.00050%0.00075%Jazz Pharmaceuticals (United States)0.00037% in 2025200020102020

Fractional works of Jazz Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%Jazz Pharmaceuticals (United States)10.8% in 2025all institutions10.0% in 20252020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.6% in 2019.

Other research institutions in Palo Alto

All research institutions in Palo Alto

Share Jazz Pharmaceuticals (United States)'s ranking

Jazz Pharmaceuticals (United States) on Science Explorer

A card with Jazz Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Jazz Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.